Curat Global’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$135K Sell
300
-50
-14% -$18.5K 0.11% 121
2026
Q1
$102K Sell
350
-200
-36% -$65.7K 0.1% 129
2025
Q4
$193K Sell
550
-50
-8% -$16.9K 0.21% 95
2025
Q3
$193K Hold
600
0.18% 97
2025
Q2
$233K Hold
600
0.22% 93
2025
Q1
$261K Buy
+600
New +$241K 0.32% 87

Other funds holding ELV

Curat Global's ELV Position: Q2 2026 in Review

Curat Global reduced its Elevance Health (ELV) stake by 14% in Q2 2026, selling an estimated $18.5K and leaving 300 shares worth $135K. The position accounts for 0.11% of the portfolio, ranked #121.

Curat Global first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. The position peaked at $261K in Q1 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Curat Global held 300 shares of Elevance Health worth $135K as of Q2 2026.
  • Curat Global sold 50 Elevance Health shares in Q2 2026, an estimated $18.5K.
  • Elevance Health made up 0.11% of Curat Global's portfolio in Q2 2026, its #121 holding.
  • Curat Global first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
  • Curat Global's Elevance Health position peaked at $261K in Q1 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Curat Global's 13F filing for Q2 2026, filed 22 Jul 2026.